Hydrogenology
Hydrogenology editorial study record

The effects of inhaling hydrogen gas on macrophage polarization, fibrosis and lung function in mice with bleomycin-induced lung injury

Aokage T et al. · BMC Pulm Med. 2021;21:339.

PreclinicalOther formsPublished 2021
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled mouse bleomycin-lung-injury experiment with 7- and 21-day comparisons

Research topic

Respiratory health

Administration classification

Other forms

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Mice with intratracheal bleomycin-induced lung injury

Sample

The article used multiple outcome-specific cohorts; complete total allocation is in a supplementary table and remains to be consolidated

Duration

6 hours/day for 7 or 21 days

Intervention

3.2% H₂ in air for 6 hours every day beginning on the day of bleomycin administration

Hydrogen form

H₂ diluted in air — not Brown’s gas.

H₂ specification

3.2% H₂ in air.

H₂ flow

Not reported — the full text gives concentration but no absolute H₂ flow in mL/min.

O₂ delivered with H₂

O₂ was present at the air fraction; no separate O₂ flow was reported.

Comparator

Bleomycin-injured mice exposed to air and corresponding non-injured controls

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Respiratory physiology, CT and histology, fibrosis, cytokines and macrophage phenotypes

Reported result

The article reports higher static compliance, lower elastance and less fibrosis-related and inflammatory change after 21 days of H₂ exposure.

Results-extraction completeness

Concentration, duration, principal physiological and tissue results, funding and conflicts checked in the open-access full text; total sample allocation awaits supplementary-table consolidation.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Preclinical bleomycin model, prolonged daily chamber exposure, multiple time points and outcome-specific sample sizes.

Applies directly to

Bleomycin-induced inflammatory and fibrotic lung injury in mice, not human pulmonary fibrosis.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 34719405 · DOI: 10.1186/s12890-021-01712-2

Publisher access

Open-access full text is available through PMC and the publisher.

Extraction basis

Open-access PMC/publisher full text and PubMed record; no retraction or expression of concern was shown in the checked records on 7 August 2026.

Record revision

2026-08-10